Diphereline PR

Diphereline PR Use In Pregnancy & Lactation

triptorelin

Manufacturer:

Ipsen

Distributor:

Zuellig Pharma
Full Prescribing Info
Use In Pregnancy & Lactation
Pregnancy: Triptorelin should not be used during pregnancy since concurrent use of GnRH agonists is associated with a theoretical risk of abortion or foetal abnormality. Prior to treatment, potentially fertile women should be examined carefully to exclude pregnancy. Non-hormonal methods of contraception should be employed during therapy until menses resume.
3.75 mg: Reproductive studies in primates have shown no maternal toxicity or embryotoxicity, and there was no effect on parturition. Inadvertent administration of triptorelin during human pregnancy has not demonstrated a teratogenic or other fetal risk. However, it is recommended that Diphereline P.R. 3.75 mg should not be used during pregnancy or lactation.
11.25 mg: Pregnancy should be excluded before Diphereline PR is prescribed.
Breast feeding: Triptorelin should not be used during breastfeeding.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in